BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19442151)

  • 1. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.
    Smiley DA; Khalil RA
    Curr Med Chem; 2009; 16(15):1863-87. PubMed ID: 19442151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
    Khalil RA
    Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
    Masood DE; Roach EC; Beauregard KG; Khalil RA
    Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause.
    Serock MR; Wells AK; Khalil RA
    Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):165-86. PubMed ID: 18991792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.
    do Nascimento GR; Barros YV; Wells AK; Khalil RA
    Curr Hypertens Rev; 2009 Nov; 5(4):283-306. PubMed ID: 20694192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.
    Khalil RA
    Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):29-46. PubMed ID: 20210774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of estrogenic menopausal hormone therapy.
    Reslan OM; Khalil RA
    Rev Recent Clin Trials; 2012 Feb; 7(1):47-70. PubMed ID: 21864249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex steroids and vascular responses in hypertension and aging.
    Qiao X; McConnell KR; Khalil RA
    Gend Med; 2008; 5 Suppl A():S46-64. PubMed ID: 18395683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.
    Ross RL; Serock MR; Khalil RA
    Curr Cardiol Rev; 2008 Nov; 4(4):309-22. PubMed ID: 20066139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.
    Gencel VB; Benjamin MM; Bahou SN; Khalil RA
    Mini Rev Med Chem; 2012 Feb; 12(2):149-74. PubMed ID: 22070687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens and Coronary Artery Disease: New Clinical Perspectives.
    Meyer MR; Barton M
    Adv Pharmacol; 2016; 77():307-60. PubMed ID: 27451102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on menopausal hormone replacement therapy in women and cardiovascular disease.
    Valdiviezo C; Lawson S; Ouyang P
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):148-55. PubMed ID: 23422240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen Receptors in Polycystic Ovary Syndrome.
    Xu XL; Deng SL; Lian ZX; Yu K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What the Women's Health Initiative has taught us about menopausal hormone therapy.
    Chester RC; Kling JM; Manson JE
    Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.
    Katzenellenbogen BS; Katzenellenbogen JA
    Breast Cancer Res; 2000; 2(5):335-44. PubMed ID: 11250726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific regulation of genes by estrogen receptors.
    Leitman DC; Paruthiyil S; Yuan C; Herber CB; Olshansky M; Tagliaferri M; Cohen I; Speed TP
    Semin Reprod Med; 2012 Jan; 30(1):14-22. PubMed ID: 22271290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing endothelial progenitor cell function through selective estrogen receptor modulation: a potential approach to cardiovascular risk reduction.
    Cignarella A; Fadini GP
    Cardiovasc Hematol Agents Med Chem; 2010 Jul; 8(3):147-55. PubMed ID: 20513233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.